GFAP and psychiatric disorder: Other reports show a reduction in GFAP levels and decreased glial density in the prefrontal cortex, cortico-limbic areas and amygdala in both the adult brain of patients with psychiatric disorders and mouse models (Gosselin et al., 2009; Altshuler et al., 2010).